Both overexpression of eIF4E S209D and chemotherapeutic drugs activate Wnt/β-catenin by increasing β-catenin activity and Wnt/β-catenin-mediated transcription in breast cancer cells (Figures 4 and 5). The gene discussed is EIF4E; the disease is breast carcinoma.